Literature DB >> 24748409

Tolerance and safety of intravenous streptomycin therapy in patients with tuberculosis.

R Pérez Tanoira1, F Sánchez-Patán, A Jiménez Girón, R Fernández Roblas, J Esteban, M L Fernández Guerrero.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24748409     DOI： 10.1007/s15010-014-0621-5

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  4 in total

1.  Treatment of tuberculosis.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2003-06-20

2.  Development of a novel method based on liquid chromatography-evaporative light scattering detection for the direct determination of streptomycin and dihydrostreptomycin in raw materials, pharmaceutical formulations, culture media and plasma.

Authors:  Artemis K Sarri; Nikolaos C Megoulas; Michael A Koupparis
Journal:  J Chromatogr A       Date:  2006-06-23       Impact factor: 4.759

3.  Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases.

Authors:  Charles A Peloquin; Shaun E Berning; Annette T Nitta; Patricia M Simone; Marian Goble; Gwen A Huitt; Michael D Iseman; James L Cook; Douglas Curran-Everett
Journal:  Clin Infect Dis       Date:  2004-05-05       Impact factor: 9.079

4.  Intravenous streptomycin: a useful route of administration.

Authors:  J T Morris; R H Cooper
Journal:  Clin Infect Dis       Date:  1994-12       Impact factor: 9.079
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.